Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial

In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.
Medscape Medical News